About Omega Therapeutics
Omega Therapeutics is a company based in Cambridge (United States) founded in 2016 by David Berry.. Omega Therapeutics has raised $211 million across 3 funding rounds from investors including Fidelity Investments, Mirae Asset and BlackRock. The company has 93 employees as of December 31, 2023. Omega Therapeutics operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
- Headquarter Cambridge, United States
- Employees 93 as on 31 Dec, 2023
- Founders David Berry
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Omega Therapeutics, Inc.
-
Annual Revenue
$3.09 M49as on Dec 31, 2023
-
Net Profit
$-97.43 M5as on Dec 31, 2023
-
EBITDA
$-100.26 M2as on Dec 31, 2023
-
Total Equity Funding
$211 M (USD)
in 3 rounds
-
Latest Funding Round
$126 M (USD), Series C
Mar 30, 2021
-
Investors
Fidelity Investments
& 7 more
-
Employee Count
93
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Omega Therapeutics
Omega Therapeutics has successfully raised a total of $211M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $126 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $126.0M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series C - Omega Therapeutics | Valuation | Invus , Logos |
|
| Jul, 2020 | Amount | Series B - Omega Therapeutics | Valuation | Flagship Pioneering | |
| Jun, 2016 | Amount | Series A - Omega Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Omega Therapeutics
Omega Therapeutics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, Mirae Asset and BlackRock. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term private equity investments in transformational opportunities are pursued.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on the biotechnology sector
|
Founded Year | Domain | Location | |
|
Life sciences-focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Omega Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Omega Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Omega Therapeutics Comparisons
Competitors of Omega Therapeutics
Omega Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Omega Therapeutics
Frequently Asked Questions about Omega Therapeutics
When was Omega Therapeutics founded?
Omega Therapeutics was founded in 2016.
Where is Omega Therapeutics located?
Omega Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Omega Therapeutics a funded company?
Omega Therapeutics is a funded company, having raised a total of $211M across 3 funding rounds to date.
How many employees does Omega Therapeutics have?
As of Dec 31, 2023, the latest employee count at Omega Therapeutics is 93.
What is the annual revenue of Omega Therapeutics?
Annual revenue of Omega Therapeutics is $3.09M as on Dec 31, 2023.
What does Omega Therapeutics do?
Omega Therapeutics was founded in 2016 and is based in Cambridge, United States. A proprietary platform known as GenomStats is employed to regulate genomic expression without modifying nucleic acid sequences. Focus is placed on precision medicine applications for rare genetic diseases, immunology, inflammation, metabolic disorders, and oncology. Operations center on advancing therapeutic solutions in the biotechnology sector.
Who are the top competitors of Omega Therapeutics?
Omega Therapeutics's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
Who are Omega Therapeutics's investors?
Omega Therapeutics has 8 investors. Key investors include Fidelity Investments, Mirae Asset, BlackRock, TD Securities, and Flagship Pioneering.